rapilysin
actavis group ptc ehf - reteplază - infarct miocardic - agenți antitrombotici - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.
multihance 529 mg/ml
bracco imaging s.p.a. - italia - acid gadobenicum - sol. inj. - 529mg/ml - medii de contrast pentru irm medii de contrast paramagnetice
octaplaslg 45-70 mg/ml
octapharma ab - suedia - proteine plasmatice umane de grup sanguin a,b,, 0 - sol. perf. - 45-70mg/ml - sange si substituenti de sange substituenti de sange si fractiuni proteice plasmatice
ivemend pulbere pentru solutie perfuzabila 150 mg
schering-plough central east ag - fosaprepitantum - pulbere pentru solutie perfuzabila - 150 mg
actilyse 50 mg
boehringer ingelheim pharma gmbh & co. kg - germania - alteplasum - pulb.+solv. pt. sol. inj./perf. - 50mg - antitrombotice enzime
plantaginol sirop
tis farmaceutic s.a. - romania - combinatii - sirop - alte med. pentru tratamentul ap. respirator alte med. pt. aparatul respirator
cefotaxim mip 1 g
mip pharma gmbh - germania - cefotaximum - pulb. pt. sol. inj./perf. - 1g - alte antibiotice betalactamice cefalosporine de generatia a - iii-a
cefotaxim mip 2 g
mip pharma gmbh - germania - cefotaximum - pulb. pt. sol. inj./perf. - 2g - alte antibiotice betalactamice cefalosporine de generatia a - iii-a
dacarbazina lipomed 1000 mg
lipomed gmbh - germania - dacarbazinum - pulb. pt. sol. perf. - 1000mg - agenti alchilanti alti agenti alchilanti
dacarbazina lipomed 500 mg
lipomed gmbh - germania - dacarbazinum - pulb. pt. sol. perf. - 500mg - agenti alchilanti alti agenti alchilanti